middle.news
BCAL Secures Exclusive Rights for Early Pancreatic and Ovarian Cancer Blood Tests in Australia
10:31am on Thursday 18th of September, 2025 AEST
•
Healthcare
Read Story
BCAL Secures Exclusive Rights for Early Pancreatic and Ovarian Cancer Blood Tests in Australia
10:31am on Thursday 18th of September, 2025 AEST
Key Points
Exclusive licence agreement with ClearNote Health for Avantect pancreatic and ovarian cancer tests
Tests to be integrated into BCAL’s existing Australian and New Zealand medical networks
Agreement initially for two years with option to extend six years
Tests leverage ClearNote’s epigenomics platform with high sensitivity and specificity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BDX
OPEN ARTICLE